The current PE ratio for Amgen stock as of Apr 24, 2024 is 21.74. This is calculated based on the current EPS of $12.56 and the stock price of $273.01 per share. The P/E ratio has grown by 19% from the past four quarters average of 18.3.
The average historical PE ratio of Amgen for the last ten years is 22.23. The current PE ratio of 21.74 is 2.2% below the historical average. Over the past ten years, AMGN's PE ratio was at its highest in the Dec 2017 quarter at 64.17, when the stock price was $173.9 and the EPS was $2.71. The lowest value was in the Dec 2016 quarter, when it reached 14.17 with a price of $146.21 and an EPS of $10.32.
Maximum annual increase: 352.86% in 2017
Maximum annual decrease: -76.11% in 2018
| Year | PE ratio | Change |
|---|---|---|
| 2023 | 22.93 | 6.35% |
| 2022 | 21.56 | -0.92% |
| 2021 | 21.76 | 17.37% |
| 2020 | 18.54 | -0.32% |
| 2019 | 18.6 | 21.33% |
| 2018 | 15.33 | -76.11% |
| 2017 | 64.17 | 352.86% |
| 2016 | 14.17 | -20.12% |
| 2015 | 17.74 | -24.29% |
| 2014 | 23.43 | 38.64% |
AMGN's current P/E ratio is above the 3 and 5-year historical averages, but it is below the 10-year average.
AMGN's PE ratio is lower than its peer stocks LLY and ABBV, but it is greater than JNJ's and BMY's. Amgen is presently trading at a lower PE ratio (21.74) than its peer group average of 32.35.
| Stock name | PE ratio | Market cap |
|---|---|---|
| JNJ Johnson & Johnson | 10.7 | $357.77B |
| BMY Bristol Myers Squibb Co | 12.59 | $98.8B |
| GILD Gilead Sciences Inc | 14.78 | $83.57B |
| AMGN Amgen Inc | 21.74 | $146.31B |
| BIIB Biogen Inc | 25.09 | $29.41B |
| ABT Abbott Laboratories | 32.59 | $185.47B |
| ABBV AbbVie Inc | 61.47 | $296.41B |
| PFE Pfizer Inc | 69.13 | $148.34B |
| LLY ELI LILLY & Co | 125.81 | $695.71B |
| ILMN Illumina Inc | N/A | $19.52B |
AMGN's price to earnings ratio is 21.74 as of Apr 24, 2024.
Over the last 3 years, the average price to earnings ratio for AMGN stock is 20.47.
Over the last 5 years, the average price to earnings ratio for AMGN stock is 19.33.
In the last ten years, the Dec 2017 quarter recorded the highest quarterly PE ratio at 64.17.
The current price to earnings ratio of AMGN is 2.2% lower than the 10-year historical average.
The PE ratio is calculated by dividing the most recent price of a stock by its trailing twelve months EPS. As of today (Apr 24, 2024), Amgen's stock price is $273.01. The earnings per share for the trailing twelve months (TTM) ending Dec 2023 is $12.56. Therefore, Amgen's P/E ratio for today is 21.74. PE RATIO(21.74) = STOCK PRICE($273.01) / TTM EPS($12.56)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.